Adjuvant Trial in Pancreatic Neuroendocrine Tumors

Clinical trial NCT07591493 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07591493
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Neuroendocrine Tumors (pNET)Pancreatic Neuroendocrine Tumors

Start date: 2026-09-01
Primary completion: 2035-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.